Top Markets
#1 MowCat MowCat +48.91%
#2 Velvet Velvet +30.94%
#3 Bermuda Shorts Bermuda Shorts +24.91%
#4 Derive Derive +20.62%
#5 Quack AI Quack AI +19.12%
#6 Audiera Audiera +18.88%
#7 aPriori aPriori +18.67%
#8 Biconomy Biconomy +17.86%
#9 Geodnet Geodnet +11.70%
#10 DUSK Network DUSK Network +9.97%
Coin of the day
MowCat MowCat
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Tricida, Inc. Tricida, Inc.

Tricida, Inc.

TCDA
Rangering i aksjer #35026
Tricida, Inc. operates as a biopharmaceutical firm with a primary focus on the... Tricida, Inc. operates as a biopharmaceutical firm with a primary focus on the advancement and market introduction of veverimer (TRC101). This compound, an orally ingested, non-systemic polymer, has successfully concluded its Phase III clinical trials. Veverimer is designed to address metabolic acidosis in individuals suffering from chronic kidney disease by specifically targeting and eliminating excess acid within the gastrointestinal tract. The company was established in 2013 and is headquartered in South San Francisco, California.
Aksjekurs
$0.108
Sist synkronisert: 2023-01-23
Markedsverdi
$4.56M
Endring (1 dag)
-10.00%
Endring (1 år)
0.00%
Land
US
Handel Tricida, Inc. (TCDA)

Kategori

Healthcare
Aksjeprishistorikk for Tricida, Inc. (TCDA)
Høyeste sluttskurs: $0.16 den 2023-01-01

Laveste sluttskurs: $27.95 den 2018-06-01
Aksjeprishistorikk for Tricida, Inc. fra 2018 til 2026
Årlig aksjeprisytelse
År Ytelse
2023 -15.79%
2022 -97.77%
2021 12.62%
2020 -81.33%
2019 39.94%
2018 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE